Touchlight, a leader in synthetic DNA technology, has appointed Will Downie as a key adviser to support its mission of ...

The supplemental new drug application is based on data from the Phase 2 LITESPARK-015 trial.

Vice President and General Manager of Pfizer CentreOne talks with Ben Locwin about drug development trends and challenges and Pfizer’s lightspeed approach. Contract Pharma is the premier media outlet ...

ReiThera has inked a comprehensive Master Service Agreement (MSA) with SillaJen, which establishes ReiThera as the ...

Neurocrine Biosciences Inc. has appointed Andrew Ratz, Ph.D. as Senior Vice President of Drug Development, Delivery and ...

Since its creation by a team of pharmaceutical, cold-chain management and quality assurance experts in 2004, Sentry BioPharma ...

BD, a global medical technology company, and Biosero, a developer of laboratory automation solutions, have joined forces to ...

Körber has named Oliver Weber as Chief Executive Officer Software in the Business Area Pharma. In this role, he will lead the global software business of the Business Area Pharma. In his role, Oliver ...

Veeva Systems and Zifo have partnered to help biopharmas modernize quality control (QC) operations by bringing together Veeva LIMS with Zifo’s data integration and management platform, qcKen—enabling ...

Coeptis Therapeutics Holdings Inc., a biopharmaceutical company focused on pioneering cell therapy platforms for cancer, ...